Gene Hayes

Gene Hayes is a seasoned Analytical Toxicologist at GENECO, where his extensive experience in configuring analytical laboratories for clinical toxicology has made a significant impact on the field. With a career spanning several decades, Gene has been at the forefront of pioneering drug testing methodologies, notably in the innovative use of tandem mass spectrometry for analyzing drugs in hair samples. This groundbreaking approach has opened new avenues for toxicological analysis, enabling more accurate and reliable results in clinical settings.

At GENECO, Gene is currently leading key projects focused on the establishment and optimization of clinical drug testing laboratories. His expertise encompasses instrument training, method development, and the creation of comprehensive Standard Operating Procedures (SOPs) that ensure compliance with regulatory standards. Gene plays a critical role in achieving CLIA certification for laboratories, which is essential for maintaining high-quality standards in laboratory medicine. His commitment to quality control and quality assurance programs has been instrumental in enhancing laboratory operations and ensuring the integrity of test results.

In addition to his technical skills, which include proficiency in ELISA, microscopy, and Western blotting, Gene's collaborative approach has fostered a culture of continuous improvement within his teams. His contributions to the field are further highlighted by his co-authorship of seven publications and one abstract, showcasing his commitment to advancing knowledge in analytical toxicology. Recently, Gene's focus has shifted to the burgeoning area of cannabis testing, where he is applying his expertise to develop robust testing protocols that meet the evolving demands of the industry. Through his work at GENECO, Gene Hayes continues to be a pivotal figure in the advancement of toxicological testing, ensuring that laboratories are equipped with the tools and knowledge necessary to deliver accurate and timely results in healthcare.